CAM2029 reduces liver and cyst volume growth compared to placebo Well tolerated with no new or unexpected safety findings A follow-up Phase 3 study will be discussed with regulatory authorities PLD is ...

Liver cysts were found in over 80% of patients with ADPKD but were not associated with chronic kidney disease stage, Mayo classification, PKD1 or PKD2 genotype variant, liver enzyme levels, or quality ...

Please provide your email address to receive an email when new articles are posted on . SGLT2 inhibitors vs. other agents were tied to a slower eGFR decline for adults with ADPKD and type 2 diabetes.

To measure scarring in a patient’s liver with magnet resonance imaging, a vibrator is affixed above the liver. The vibrator causes compression waves in the liver, which can be observed in the images.

Fifty percent of T2DM patients also have NAFLD, confirmed via ultrasound, with elevated liver enzymes and altered lipid profiles. NAFLD and T2DM are key components of metabolic syndrome, sharing risk ...